Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-22

Clinical Trial Update: Pierre Robin Sequence Outcome Assessment Multi Institutional Study

View source ↗

Summary

A multi-institution clinical trial evaluating outcomes in Pierre Robin sequence has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Pierre Robin Sequence | Status: WITHDRAWN